VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon May 11, 2024 6:15am

105 Views

Post# 36035015

VMS+ workshops which provided a window to the future of echo

As AEPC 2024 draws to a close I would like to thank our Ventripoint team members and distribution partners Angiopro and Cardiologic for all of their hard work preparing for, and participating in this years annual meeting. This years meeting saw a record number of registrants in attendance which speaks to the importance of this forum.

Thanks also go out to all of those delegates who visited our booth and attended the VMS+ workshops which provided a window to the future of echo AI.

#AEPC2024 #PediatricCardiology #Angiopro #Ventripoint #Cardiologic